Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul Diaz Insider Profile
4 Followers
Paul Diaz, Director at Kindred Healthcare, holds 1.07M shares in Myriad Genetics (Ticker: MYGN), holds 16.07K shares in DaVita (Ticker: DVA), holds 0.00 shares in Kindred Healthcare (Ticker: KND). Most recently, Paul Diaz Sold ― shares of Myriad Genetics on May 15, 2024 for an estimated value of 5.73M.
Profitable Transactions
3 out of 6 Profitable Transactions
Average Return
-12.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Paul Diaz holds in companies
Most Profitable Insider Trade
The most profitable trade made by Paul Diaz
Paul Diaz's Trading History
Kindred Healthcare
Jul 02, 2018
―
Uninformative Sell
3.82M
$0.00
Myriad Genetics
May 15, 2024
President & CEO, Director
Informative Sell
5.73M
$26.24M
DaVita
May 17, 2023
Director
Uninformative Buy
―
$2.19M
PharMerica Corp
―
―
―
$4.79M
List of latest transactions for each holding click on a transaction to see Paul Diaz's performance on stock
You May Also Like
Paul Diaz insider profile FAQ
What is the percentage of profitable transactions made by Paul Diaz?
The percentage of profitable transactions made by Paul Diaz is 50%.
What is the average return per transaction made by Paul Diaz?
The average return per transaction made by Paul Diaz is -12.20%.
What stocks does Paul Diaz hold?
Paul Diaz holds: KND, MYGN, DVA, PMC stocks.
What was Paul Diaz’s latest transaction?
Paul Diaz latest transaction was an Informative Sell of $5.73M.
What was Paul Diaz's most profitable transaction?
Paul Diaz’s most profitable transaction was an Informative Sell of DVA stock on March 24, 2015. The return on the trade was 12.90%.
What is Paul Diaz's role in Kindred Healthcare?
Paul Diaz's role in Kindred Healthcare is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.